Icosavax, Inc.

ICVX · NASDAQ
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Operating Activities
Net Income-$22-$26-$25-$24
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$7$6$6$6
Change in WC-$3$1-$3$8
Other Non-Cash-$1-$1-$1-$1
Operating Cash Flow-$19-$19-$22-$9
Investing Activities
PP&E Inv.-$0-$1-$2-$3
Net Acquisitions$0$0-$14$0
Inv. Purchases-$112$0-$50-$50
Inv. Sales/Matur.$40$57$64$49
Other Inv. Act.$0$0$14-$3
Investing Cash Flow-$73$56$12-$7
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued-$0$68$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$68$0$10
Financing Cash Flow-$0$68$0$10
Forex Effect$0$0$0$0
Net Chg. in Cash-$92$105-$10-$6
Supplemental Information
Beg. Cash$155$50$60$66
End Cash$63$155$50$60
Free Cash Flow-$19-$20-$23-$12